» Relipidated recombinant human tissue Factor protein

HEMOSTASIS COAGULATION RESEARCH PLASMA DERIVED PROTEINS TISSUE FACTOR

Relipidated recombinant human tissue Factor protein

Formulation: 50mM tris buffer, 100mM NaCl, pH 7.6 and 200 mg / mL of trehalose.

Structure: The protein contains amino acids 1 to 263 including the extracellular, transmembrane and cytoplasmic domains.
MW(Da) : 45 000 Usage : 1-step coagulation test.

Reference	11-4500L/B
Presentation	Vial
Format	250 ng
Quote

Price list, safety data sheets and notices are accessible to our registered customers.

Reference	Presentation	Format	Quote	Product sheet
11-4500L/B	Vial	250 ng

Price list, safety data sheets and notices are accessible to our registered customers.

Tissue factor (FT) is a transmembrane glycoprotein which is primarily responsible for activating coagulation cascades in the event of a vascular breach. The binding of FVII to its receptor, expressed by the cells of the subendothelium exposed by the lesion, allows its very rapid activation by traces of FXa, circulating in trace amounts in vivo. The FT-FVIIa complex then causes the activation of FIX and FX and the formation of thrombin.

All proteins are accompanied by certificates of analysis which describe the appropriate storage conditions. In order for us to guarantee the stability of the product, it is imperative that the storage conditions are observed. To be taken up with 0.5 mL of distilled water to generate a solution of 500 nG / mL. Aliquot and freeze at -70 ° C to avoid freeze / thaw cycles.

The lyophilized presentation allows greater stability until the expiration date.

Recombinant human tissue factor
Recombinant tissue Factor

	These kits are manufactured in accordance with the 98/79 EC directive for in vitro diagnostic devices. Only CE marked products can be used for diagnostic applications in Europe.
	These kits are intended for in vitro diagnostic use.
	These kits are for research use only and are not intended to be used for diagnostic procedures.
	Federal Drug Administration, FDA validates diagnostic kits for in vitro diagnostic use in the United States.
	Biological risk products.
	Storage between 2 and 8 ° C.
	Reactive in liquid form.
	Reactive in lyophilized form.
	Reactive in frozen form.
	Stability after opening at 2-8 ° C.
	Products that can be refrozen.
	Stability 12 months after refreezing at -20 ° C.
	Manufacturer.
	Importer
	Distributor.

HEMOSTASIS COAGULATION RESEARCH PLASMA DERIVED PROTEINS TISSUE FACTOR